I have never taken viagra. I have 50 mg script but i am getting second thoughts about taking it because of side effects.

Sildenafil is a sensitive CYP3A4 substrate; nelfinavir is a strong CYP3A4 inhibitor.

Dosing & Uses

A similar decrease in the concentration of d-nebivolol (less than 20% in the AUC) was also observed with coadministration of sildenafil. Nebivolol; Valsartan: (Moderate) Monitor closely for decreased efficacy of either drug if sildenafil is coadministered with nebivolol. Nefazodone: (Major) Coadministration of nefazodone is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving nefazodone. Nelfinavir: (Major) Sildenafil is contraindicated for use with nelfinavir when used viagra tablet for sex for pulmonary arterial hypertension (PAH). Nesiritide, BNP: (Major) No formal drug interaction trials have been conducted with nesiritide.

• The drug's action is localized to the penis; systemic effects are generally mild.
• Starting at a low dose allows assessment of individual pharmacokinetics.
• It is not a "party drug" and using it recreationally can be hazardous.
• Men with multiple myeloma or leukemia may have contraindications.
• Can be used by men who have undergone kidney transplantation, with doctor approval.
• The cost-effectiveness of generic sildenafil has increased treatment access.
• Some men may find the side effects diminish with continued use.
• It does not treat underlying vascular disease, a common cause of ED.
• Penile implants or injections are alternatives if oral therapy fails.
• The decision to use medication should be a shared one between patient and doctor.
• Regular check-ups are important to monitor for any new health developments.

Sildenafil use within 24 hours was an exclusion criteria for nesiritide treatment during clinical trials.

• 25 mg Viagra may be recommended for men with mild to moderate ED.
• The medication’s effects typically last around 4-6 hours.
• Missing a dose is not typical since Viagra is used as needed.
• To maximize safety, inform your doctor of all health conditions.
• Patients should avoid grapefruit or grapefruit juice when taking Viagra.
• Ensure adequate hydration when using Viagra to prevent dehydration.
• Follow up with your doctor if Viagra doesn't produce expected results.

Although not identified during clinical trials, the potential for symptomatic hypotension may be significantly increased when coadministering nesiritide with sildenafil.

Sildenafil should be avoided within 24 hours before or after nesiritide use.

• 25 mg Viagra is a lower dose used for mild erectile dysfunction.
• Typical starting dose for Viagra is 50 mg, but 25 mg can be prescribed for sensitive users.
• 25 mg Viagra may have fewer side effects compared to higher doses.
• It is taken approximately 30-60 minutes before sexual activity.
• Avoid heavy meals before taking 25 mg Viagra for faster absorption.
• Men with certain health conditions should consult a doctor before use.
• Alcohol intake can reduce the effectiveness of 25 mg Viagra.

Netupitant, Fosnetupitant; Palonosetron: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with netupitant; palonosetron is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction.

See also:

In two of the six subjects, prolonged clinical effects of sildenafil were noted for 72 hours after a single dose of sildenafil. Isavuconazonium: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with isavuconazonium is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction. Isocarboxazid: (Moderate) Additive hypotensive effects may be seen when monoamine oxidase inhibitors (MAOIs) are combined with sildenafil. Careful monitoring of blood pressure is suggested during concurrent therapy of MAOIs with sildenafil. It can be expected that concomitant administration of CYP3A4 enzyme-inducers, such as rifampin, will decrease plasma levels of sildenafil, however, no interaction studies have been performed.

How to take it

Isoniazid, INH; Rifampin: (Minor) Sildenafil is metabolized principally by cytochrome P450 3A4 and 2C9 enzymes. Itraconazole: (Major) Avoid use of sildenafil for the treatment of pulmonary hypertension during and for 2 weeks after discontinuation of itraconazole treatment. When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving itraconazole. Ivacaftor: (Moderate) Increased monitoring is recommended if ivacaftor is administered concurrently with CYP2C9 substrates, such as sildenafil. Ivosidenib: (Moderate) Monitor for loss of efficacy of sildenafil during coadministration of ivosidenib; a sildenafil dose adjustment may be necessary. Nevirapine: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with nevirapine is necessary as concurrent use may decrease sildenafil exposure.

Sildenafil is a sensitive CYP3A substrate and nevirapine is a weak CYP3A inducer.

Route of administration

Lesinurad; Allopurinol: (Moderate) Lesinurad may decrease the systemic exposure and therapeutic efficacy of sildenafil; monitor for potential reduction in efficacy. Letermovir: (Major) Monitor for an increase in sildenafil-related adverse reactions if coadministration with letermovir is necessary; a dose reduction of sildenafil may be necessary when prescribed for erectile dysfunction. Concurrent use is not recommended in patients receiving sildenafil for pulmonary arterial hypertension and taking cyclosporine, because the magnitude of the interaction may be amplified. Consider a starting dose of 25 mg of sildenafil for erectile dysfunction in patients receiving letermovir with cyclosporine. Letermovir is a moderate CYP3A4 inhibitor; however, when given with cyclosporine, the combined effect on CYP3A4 substrates is similar to a strong CYP3A4 inhibitor.

How to relieve Viagra side effects

Levamlodipine: (Moderate) Monitor for additive hypotension if amlodipine is administered concurrently with sildenafil, as both agents act independently to reduce blood pressure. Levoketoconazole: (Major) Coadministration of ketoconazole is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). Lonafarnib: (Major) Coadministration with lonafarnib is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving lonafarnib. Lopinavir; Ritonavir: (Major) Coadministration of ritonavir is contraindicated in patients receiving sildenafil for pulmonary arterial hypertension (PAH). Nicardipine: (Moderate) Nicardipine is an inhibitor of CYP3A4 isoenzymes.

• Starting with 25 mg minimizes risk while determining individual response.
• The medication does not accumulate in the body with single, as-needed use.
• Severe allergic reactions (rash, swelling, difficulty breathing) are rare.
• Can interact with certain antibiotics and antifungal medications.
• Patients with retinitis pigmentosa have a higher risk of vision complications.
• An erection lasting more than 4 hours requires urgent urological care.
• Do not increase the dose without consulting your prescribing physician.
• Buying from unverified international websites carries significant health risks.
• It is not a performance-enhancing drug for athletes and is banned in some sports.
• Can be used by men with diabetes, but efficacy may be somewhat reduced.
• Open communication with your partner about ED treatment is often beneficial.

Co-administration with nicardipine may lead to an increase in serum levels of drugs that are CYP3A4 substrates, such as sildenafil.

Similar questions

Concurrent use substantially increases the sildenafil plasma concentrations and may result in increased associated adverse events including hypotension, syncope, visual changes, and prolonged erection. Ritonavir, a strong CYP3A4 inhibitor, increased the AUC of sildenafil, a sensitive CYP3A4 substrate, by 11-fold in a drug interaction study. Lorcaserin: (Moderate) buy viagra connect online Lorcaserin is a serotonin 2C receptor agonist, and priapism is a potential effect of 5-HT2C receptor agonism. Because there is little experience with the combination of lorcaserin and medications indicated for erectile dysfunction (e.g., phosphodiesterase inhibitors), combined use should be approached with caution. Lorlatinib: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with lorlatinib is necessary as concurrent use may decrease sildenafil exposure.

Administration Notes

Lumacaftor; Ivacaftor: (Moderate) Increased monitoring is recommended if ivacaftor is administered concurrently with CYP2C9 substrates, such as sildenafil. If concurrent use of lurasidone and antihypertensive agents is necessary, patients should be counseled on measures to prevent orthostatic hypotension, such as sitting on the edge of the bed for several minutes prior to standing in the morning and rising slowly from a seated position. Close monitoring of blood pressure is recommended until the full effects of the combination therapy are known. Mavacamten: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with mavacamten is necessary as concurrent use may decrease sildenafil exposure. Mifepristone: (Major) Coadministration with mifepristone is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). Nifedipine: (Moderate) Nifedipine can have additive hypotensive effects when administered with phosphodiesterase inhibitors (PDE 5 inhibitors).

Overdose/Missed Dose

Sildenafil is a sensitive substrate of CYP3A4; ivosidenib induces CYP3A4 and may lead to decreased sildenafil concentrations. Ketoconazole: (Major) Coadministration of ketoconazole is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving ketoconazole. Lansoprazole; Amoxicillin; Clarithromycin: (Major) Coadministration of clarithromycin is not recommended in patients receiving sildenafil for pulmonary arterial hypertension (PAH). Lefamulin: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with oral lefamulin is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction.

Can women take Viagra?

Sildenafil is a sensitive CYP3A4 substrate and oral lefamulin is a moderate CYP3A4 inhibitor; an interaction is not expected with intravenous lefamulin. Lenacapavir: (Moderate) Monitor for an increase in sildenafil-related adverse reactions if coadministration with lenacapavir is necessary; consider a starting dose of 25 mg of sildenafil when prescribed for erectile dysfunction. Sildenafil is a sensitive CYP3A substrate and lenacapavir is a moderate CYP3A inhibitor. In a drug interaction study, coadministration with a moderate CYP3A inhibitor increased the AUC of sildenafil by 182%. Lesinurad: (Moderate) Lesinurad may decrease the systemic exposure and therapeutic efficacy of sildenafil; sildenafil viagra price monitor for potential reduction in efficacy. The patient should be monitored carefully and the dosage should be adjusted based on clinical response. For example, in patients whose hypertension was controlled with nifedipine, vardenafil produced mean additional supine systolic/diastolic blood pressure reductions of 3 to 4 mmHg (age group 65 to 69 years) and 5 to 6 mmHg (age group 70 to 80 years) compared to placebo.

Find related categories

When sildenafil is used for erectile dysfunction, consider a starting dose of 25 mg for patients receiving mifepristone. Sildenafil is a sensitive CYP3A substrate and mifepristone is a strong CYP3A inhibitor. Mitapivat: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with mitapivat is necessary as concurrent use may decrease sildenafil exposure. Mitotane: (Major) Use caution if mitotane and sildenafil are used concomitantly, and monitor for decreased efficacy of sildenafil and a possible change in dosage requirements. Mitotane is a strong CYP3A4 inducer and sildenafil is a CYP3A4 substrate; coadministration may result in decreased plasma concentrations of sildenafil.

Does Viagra help me keep an erection after ejaculation?

Population pharmacokinetic analysis of data from patients in clinical trials indicated approximately 3-fold the sildenafil clearance when it was co-administered with mild CYP3A inducers. Mobocertinib: (Moderate) Monitor for decreased efficacy of sildenafil if coadministration with mobocertinib is necessary as concurrent use may decrease sildenafil exposure. Monoamine oxidase inhibitors: (Moderate) Additive hypotensive effects may be seen when monoamine oxidase inhibitors (MAOIs) are combined with sildenafil. Nebivolol: (Moderate) Monitor closely for decreased efficacy of either drug if sildenafil is coadministered with nebivolol. The AUC of sildenafil was decreased by 21% when coadministered with nebivolol.